Abstract
The characterization of the pharmacokinetic profile of anti-tumor B (ATB) in oral cancer patients
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have